MALIGNANT GLIOMA
Clinical trials for MALIGNANT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT GLIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain cancer fight: adding Whole-Brain radiation to stop tumor return
Disease control CompletedThis study tested whether adding whole-brain radiation therapy and a drug called plerixafor to the standard treatment could better control an aggressive type of brain tumor called glioblastoma (GBM). It involved 21 adults who had recently been diagnosed and had surgery. The main …
Matched conditions: MALIGNANT GLIOMA
Phase: PHASE2 • Sponsor: Lawrence D Recht • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New weapon tested against deadly recurrent brain tumors
Disease control CompletedThis early-stage study tested a new drug called D2C7-IT in adults whose aggressive brain cancer (malignant glioma) had returned. The main goal was to find the safest dose by delivering the drug directly into the tumor through tiny catheters over 72 hours. Researchers enrolled 81 …
Matched conditions: MALIGNANT GLIOMA
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New scan aims to sharpen brain cancer treatment
Diagnosis CompletedThis study tested whether adding a special type of PET scan (called 18F-DOPA-PET) to standard MRI could help doctors more accurately plan radiation therapy for people with newly diagnosed malignant brain tumors (gliomas). The goal was to see if this combined imaging approach coul…
Matched conditions: MALIGNANT GLIOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC